Facebook Live Series - ASK THE DOC: Alzheimer's Research Today! This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) the first Friday of every month from 9:00-9:30 AM PST to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Episode 3: "Is Alzheimer's an immune disorder?" This month, we're joined by Andrea Tenner, PhD. Dr. Tenner earned her PhD from UC San…
Read More
Tune in this Friday, April 5 @ 9AM for the next episode of our monthly Facebook LIVE series, "Is Alzheimer's an immune disorder?" This month, we're joined by Andrea Tenner, PhD. Dr. Tenner earned her PhD from UC San Diego and is an esteemed Professor in the UC Irvine School of Medicine and the School of Biological Sciences. Throughout her career, Dr. Tenner has received numerous academic awards and has published over 100 scientific journal articles. Dr. Tenner’s research examines the role of inflammation and how our body’s immune system responds to Alzheimer’s disease – and using this knowledge, her team…
Read More
Ira Lott, MD Did you know that people with Down syndrome are at significantly increased risk to develop Alzheimer's disease? UCI MIND researchers, like Ira Lott, MD, Eric Doran, MS, Elizabeth Head, PhD, and Jorge Busciglio, PhD aim to better understand this critical link to improve quality of life and bring us closer to improved treatments and prevention for all people impacted by Alzheimer’s disease. To learn more about the UCI MIND Down Syndrome Program, click here > To read a recent interview with Down Syndrome Program manager, Eric Doran, click here >. In this post, Eric discusses the creation…
Read More
Contributed by Joshua Grill, PhD, Director of UCI MIND The global research effort to find effective treatments for Alzheimer’s disease has suffered another disappointing setback. Biogen announced today that the company will halt the parallel large Phase 3 trials of the monoclonal antibody against the amyloid beta protein, aducanumab. This treatment was viewed by many to hold tremendous promise. Early results were unprecedented. Patients with Alzheimer’s disease who were treated with aducanumab showed significant reduction in amyloid burden in the brain, which appeared to slow disease progression. The results were based on a small number of participants, however, and were not…
Read More
People ages 50 and older who have memory problems are needed for a new clinical trial for Mild Cognitive Impairment and Alzheimer’s disease at the University of California, Los Angeles and University of California, Irvine. The NEAT study is a clinical trial sponsored by the University of California “Cures for Alzheimer’s Initiative,” testing whether nicotinamide, a component of vitamin B3, can slow Alzheimer’s disease. Specifically, the 12-month study is investigating if a high daily dose of nicotinamide can affect the brain tangles associated with Alzheimer’s disease. The study also measures whether nicotinamide is effective in improving memory and other thinking…
Read More
Facebook Live Series - ASK THE DOC: Alzheimer's Research Today! This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) the first Friday of every month from 9:00-9:30 AM PST to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Episode 2: "What causes memory problems in older adults?" Dr. Ahmad Sajjadi is Assistant Professor of Neurology in the UCI School of Medicine.…
Read More
Chelsea holding her father's hand at a psychiatric hospital, days before he passed away with Alzheimer's disease at the age of 61 In an interview with UCI undergraduate students, Chelsea Cox, Associate Director of Eduction for UCI MIND, shares her personal journey with Alzheimer's disease, her perspective on care and research, and how people - young and old - can get involved in the cause. "...No one should have to spend their final days that way. This experience is what motivated me to get involved in Alzheimer’s research and education. So that hopefully, one day, other people don’t have to…
Read More
Tune in this Friday, March 1 @ 9AM for the next episode of our monthly Facebook LIVE series, "What causes memory problems in older adults?" This month, we're joined by Ahmad Sajjadi, MD, PhD, Assistant Professor of Neurology in the UCI School of Medicine. Dr. Sajjadi received his medical degree from Tehran University of Medical Sciences in Iran and his PhD from the University of Cambridge in the UK. Dr. Sajjadi is a behavioral neurologist who sees patients with memory concerns and also conducts research on Alzheimer’s disease and atypical forms of dementia. To attend live and ask questions, login…
Read More
